CAS 274901-16-5 Mimọ ≥99.0% (HPLC) API
| Awọn itumọ ọrọ sisọ | LAF-237 |
| Nọmba CAS | 274901-16-5 |
| NỌMBA CAT | RF-API30 |
| Iṣura Ipo | Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn ọgọọgọrun Kilogram |
| Fọọmu Molecular | C17H25N3O2 |
| Òṣuwọn Molikula | 303.4 |
| Brand | Ruifu Kemikali |
| Nkan | Awọn pato |
| Ifarahan | Funfun Crystalline Powder |
| Idanimọ | IR, HPLC: Gbọdọ ni ibamu si Iwọn Itọkasi naa |
| Specific Optical Yiyi | -82,0 ° to -92,0 ° |
| Ojuami Iyo | 148.0 ~ 152.0 ℃ |
| Pipadanu lori Gbigbe | ≤0.50% |
| Aloku lori Iginisonu | ≤0.10% |
| Awọn irin Heavy | ≤20ppm |
| Sulfate | ≤0.02% |
| Kloride | ≤0.05% |
| Chiral Aimọ | Aimọ R-Isomer ≤0.50% |
| Awọn ohun elo ti o ku | |
| Acetonitrile | ≤410ppm |
| Dichloromethane | ≤600ppm |
| isopropyl Ọtí | ≤5000ppm |
| Awọn Idẹ ti o jọmọ | Nipasẹ HPLC |
| Aimọ́ A | ≤0.15% |
| Aimọ́ B | ≤0.15% |
| Iwa aimọ C | ≤0.20% |
| Miiran Single aimọ | ≤0.10% |
| Lapapọ Awọn Aimọ | ≤1.00% |
| Mimọ / Analysis Ọna | ≥99.0% (HPLC) |
| Igbeyewo Standard | Standard Enterprise |
| Lilo | API, Àtọgbẹ Àtọgbẹ Iru 2 (T2DM) |
Package: Igo, apo bankanje aluminiomu, 25kg / Paali ilu, tabi gẹgẹ bi ibeere alabara
Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina, ọrinrin
Shanghai Ruifu Chemical Co., Ltd jẹ olupilẹṣẹ asiwaju ati olupese ti API (CAS: 274901-16-5) pẹlu didara to gaju.API (CAS: 274901-16-5)jẹ aṣoju egboogi-hyperglycemic ti ẹnu (oògùn egboogi-diabetic) ti ẹgbẹ inhibitor dipeptidyl peptidase-4 (DPP-4) tuntun ti awọn oogun.O jẹ idagbasoke nipasẹ Novartis (Novartis) Pharmaceutical Co., Ltd, jẹ inhibitor ti ẹnu miiran ti Dipeptidyl peptidase-IV.Ni ọdun 2008, o fọwọsi fun tita ni European Union fun itọju iru àtọgbẹ 2.API (CAS: 274901-16-5) ṣe idiwọ aisedeedee ti GLP-1 ati GIP nipasẹ DPP-4, gbigba GLP-1 ati GIP lati ni agbara yomijade ti hisulini ninu awọn sẹẹli beta ati dinku itusilẹ glucagon nipasẹ awọn sẹẹli alpha ti Awọn erekusu ti Langerhans ninu oronro.API (CAS: 274901-16-5) ti ṣe afihan lati dinku hyperglycemia ni iru 2 diabetes mellitus.
